Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.
A 24-kDa recombinant protein from Trypanosoma cruzi (rTc24) was evaluated by enzyme-linked immunosorbent assay (ELISA) and Western blot (immunoblot) tests to identify treated chagasic patients considered parasitologically cured on the basis of persistently negative tests of hemocultures and lytic an...
Guardado en:
| Publicado en: | J Clin Microbiol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1995
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC228340/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7559953/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.33.8.2086-2090.1995 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
